Pancreatic Cancer Research

ResearcherGuangxi Medical UniversityNo recent work listed

Long Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8677-803X; OpenAlex author ID A5100336373. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers

Papers 3

  1. CIRBP Regulates Pancreatic Cancer Cell Ferroptosis and Growth by Directly Binding to p53. Last author DOI 10.1155/2022/2527210↗
  2. Development of a Gene Risk Signature for Patients of Pancreatic Cancer. First author DOI 10.1155/2022/4136825↗
  3. Tea drinking and risk of pancreatic cancer. First author DOI 10.3760/cma.j.issn.0366-6999.20140688↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tao Liu · 1 shared paper, 2022 · strength 0.16
  2. Ju‐Dong Li · 1 shared paper, 2022 · strength 0.16
  3. Xing Liang · 1 shared paper, 2022 · strength 0.16
  4. Chenghao Shao · 1 shared paper, 2022 · strength 0.16
  5. Hongqiang Gao · 1 shared paper, 2022 · strength 0.15
  6. Wei Junbao · 1 shared paper, 2014 · strength 0.07
  7. Zhu Xiaodong · 1 shared paper, 2014 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.